The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Multi-Stakeholder Workshop / November 2021

Gene-and Cell Therapies in Oncology

29-30 November 2021, Online Workshop


On behalf of the Cancer Drug Development Forum, its partners, and my colleagues from the program committee, I would like to welcome you to the 2021 CDDF Multi-Stakeholder  CDDF Workshop: Gene- and Cell Therapies in Oncology.

We have brought together experts from academia, regulators, industry and patient groups to explore a range of aspects in this important and still rather novel approach in cancer drug development. Over the 2 days of the workshop, we will explore the development of gene- and cell therapies, both from the scientific and clinical trial perspective, as well as a looking at approval pathways on both sides of the Atlantic. Furthermore, we will discuss how to improve patient access and explore future perspectives of this innovative therapeutic approach.

This will be the first official hybrid event organized by CDDF. The workshop has been set up to allow for exchange and interactions, regardless if you are joining us in person or online. Due to the recent developments, we realise that many attendees will be joining us virtually. Nevertheless, we are looking forward to an interactive meeting with plenty of opportunities for robust discussions, e.g., multi-stakeholder panels at the end of each session and online networking opportunities.

We are looking forward to the discussions with you, and to fulfill our mission to facilitate cancer drug development.

Catarina Edfjäll

CDDF Board member

Online Workshop

Due to the latest measures implemented by the Dutch government, the CDDF had to make the difficult decision to move the CDDF workshop on Gene and Cell Therapies to a fully online event. We are looking forward to seeing you again in person soon!

Programme update

The CDDF decided to slightly adapt the programme to allow the international participants to attend the entire workshop. You can find the updated programme at this link

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70